Cerebral involvement of metastatic thymic carcinomaKONG, Doo-Sik; LEE, Jung-Il; DO HYUN NAM et al.Journal of neuro-oncology. 2005, Vol 75, Num 2, pp 143-147, issn 0167-594X, 5 p.Article

Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN studyWU, Yi-Long; KIM, Joo-Hang; PARK, Keunchil et al.Lung cancer. 2012, Vol 77, Num 2, pp 339-345, issn 0169-5002, 7 p.Article

The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancerYOUNG SAING KIM; SUN, Jong-Mu; JIN SEOK AHN et al.Lung cancer. 2013, Vol 81, Num 2, pp 231-235, issn 0169-5002, 5 p.Article

Effects of transforming growth factor β (TGF-β) receptor on lung carcinogenesisPARK, Chaehwa; KIM, Won-Seog; CHOI, Yunseon et al.Lung cancer. 2002, Vol 38, Num 2, pp 143-147, issn 0169-5002, 5 p.Article

A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic CancerJUN HO YI; LEE, Jeeyun; YOUNG SUK PARK et al.Oncology. 2011, Vol 80, Num 3-4, pp 175-180, issn 0030-2414, 6 p.Article

Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsSUN, Jong-Mu; MI HYUN NAM; JAE YONG CHUNG et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 531-538, issn 0344-5704, 8 p.Article

Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsSUN, Jong-Mu; AHN, Myung-Ju; MIN JAE PARK et al.Lung cancer. 2010, Vol 69, Num 1, pp 105-109, issn 0169-5002, 5 p.Article

Prognostic Model to Predict Outcomes in Non-Small Cell Lung Cancer Patients with Erlotinib as Salvage TreatmentSEUNG TAE KIM; LEE, Jeeyun; SUN, Jong-Mu et al.Oncology. 2010, Vol 79, Num 1-2, pp 78-84, issn 0030-2414, 7 p.Article

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III studySCAGLIOTTI, Giorgio V; PARK, Keunchil; PATIL, Shekar et al.European journal of cancer (1990). 2009, Vol 45, Num 13, pp 2298-2303, issn 0959-8049, 6 p.Article

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapyJI EUN UHM; YEON HEE PARK; WON KI KANG et al.International journal of cancer (Print). 2009, Vol 124, Num 6, pp 1457-1462, issn 0020-7136, 6 p.Article

Metabolic Tumor Volume of [¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal CancerMAN KI CHUNG; JEONG, Han-Sin; KIM, Hyung-Jin et al.Clinical cancer research (Print). 2009, Vol 15, Num 18, pp 5861-5868, issn 1078-0432, 8 p.Article

Protein profiling in human sera for identification of potential lung cancer bipmarkers using antibody microarrayHAN, Min-Kyu; OH, Young-Hee; KANG, Jimin et al.Proteomics (Weinheim. Print). 2009, Vol 9, Num 24, pp 5544-5552, issn 1615-9853, 9 p.Article

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphomaPARK, Sarah; LEE, Jeeyun; KIM, Kihyun et al.Blood. 2007, Vol 110, Num 3, pp 972-978, issn 0006-4971, 7 p.Article

Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancerPARK, Jinny; BYUNG BAE PARK; KIM, Kihyun et al.Clinical cancer research. 2004, Vol 10, Num 13, pp 4383-4388, issn 1078-0432, 6 p.Article

Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancerYONG CHAN AHN; PARK, Keunchil; DO HOON LIM et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 5, pp 588-592, issn 0284-186XArticle

Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beaconsJO, Seong-Min; KIM, Youngwook; JEONG, Young-Su et al.Biosensors & bioelectronics. 2013, Vol 46, pp 142-149, issn 0956-5663, 8 p.Article

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non―Small-Cell Lung Cancer: MONET 1SCAGLIOTTI, Giorgio V; VYNNYCHENKO, Ihor; DEDIU, Mircea et al.Journal of clinical oncology. 2012, Vol 30, Num 23, pp 2829-2836, issn 0732-183X, 8 p.Article

Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary glandSUNG, Ji-Youn; HEE KYUNG AHN; KWON, Ji-Eun et al.Journal of oral pathology & medicine. 2012, Vol 41, Num 5, pp 415-423, issn 0904-2512, 9 p.Article

EXPRESSION OF EXCISION REPAIR CROSS-COMPLEMENTATION GROUP 1 AS PREDICTIVE MARKER FOR NASOPHARYNGEAL CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPYSUN, Jong-Mu; AHN, Myung-Ju; YONG CHAN AHN et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 3, pp 655-660, issn 0360-3016, 6 p.Article

Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neckSUN, Jong-Mu; HYUN JUNG JUN; YOUNG HYEH KO et al.Oral oncology (1997). 2011, Vol 47, Num 8, pp 714-719, issn 1368-8375, 6 p.Article

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancyLEE, Soohyeon; KIM, Youngwook; AHN, Myung-Ju et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 8, pp 1203-1211, issn 0171-5216, 9 p.Article

Comparison of Gefitinib Versus Erlotinib in Patients With Nonsmall Cell Lung Cancer Who Failed Previous ChemotherapySEUNG TAE KIM; LEE, Jeeyun; KIM, Jeong-Hoon et al.Cancer. 2010, Vol 116, Num 12, pp 3025-3033, issn 0008-543X, 9 p.Article

Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 yearsJI HYE MIN; HO YUN LEE; KYUNG SOO LEE et al.Lung cancer. 2010, Vol 69, Num 1, pp 123-126, issn 0169-5002, 4 p.Article

Prognostic Model to Predict Outcomes in Nonsmall Cell Lung Cancer Patients Treated With Gefitinib as a Salvage TreatmentMIN JAE PARK; LEE, Jeeyun; JUNG YONG HONG et al.Cancer. 2009, Vol 115, Num 7, pp 1518-1530, issn 0008-543X, 13 p.Article

Adenocarcinoma has an excellent outcome with pemetrexed treatment in Korean patients: A prospective, multicenter trialLEE, Hui-Young; AHN, Myung-Ju; CHOI, Kwon et al.Lung cancer. 2009, Vol 66, Num 3, pp 338-343, issn 0169-5002, 6 p.Article